Invenomic Capital Management’s SRAX, Inc. Class A Common Stock SRAX Stock Holding History

Invenomic Capital Management’s Portfolio SRAX Stock Details SRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16,483	Closed	-$78K	–	161
2021 Q1	$78K	Sell	16,483 -1,998	-11%	-$8.35K	0.02%	118
2020 Q4	$57K	Sell	18,481 -4,018	-18%	-$10.7K	0.01%	138
2020 Q3	$67K	Sell	22,499 -98,646	-81%	-$268K	0.04%	138
2020 Q2	$307K	Hold	121,145	–	–	0.23%	111
2020 Q1	$244K	Sell	121,145 -9,767	-7%	-$23.2K	0.2%	114
2019 Q4	$326K	Buy	+130,912	New	+$218K	0.13%	104

Other funds holding SRAX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IECM

Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCA

Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Invenomic Capital Management's SRAX Position: Q2 2021 in Review

Invenomic Capital Management sold out of SRAX, Inc. Class A Common Stock (SRAX) in Q2 2021, closing a stake of 16,483 shares — an estimated $78K sold.

Invenomic Capital Management first reported a position in SRAX in Q4 2019 and held it in 6 quarters. The position peaked at $326K in Q4 2019. 32 funds tracked by Wall St. Rank hold SRAX as of Q2 2021.

Invenomic Capital Management reported no remaining SRAX, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
Invenomic Capital Management sold 16,483 SRAX, Inc. Class A Common Stock shares in Q2 2021, an estimated $78K.
Invenomic Capital Management first reported a position in SRAX, Inc. Class A Common Stock in Q4 2019 and held it in 6 quarters.
Invenomic Capital Management's SRAX, Inc. Class A Common Stock position peaked at $326K in Q4 2019.
32 funds tracked by Wall St. Rank held SRAX, Inc. Class A Common Stock as of Q2 2021.

Based on Invenomic Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.